BioCentury
ARTICLE | Company News

Gliatech other research news

November 13, 2000 8:00 AM UTC

GLIA said it cloned multiple forms of the glycine transporter in the human brain and has characterized the regional distribution of the isoforms. The company suggested that inhibition of glycine transport could be useful to treat schizophrenia and other CNS disorders. Data were presented at the Society for Neuroscience meeting in New Orleans. ...